These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 3724304)

  • 41. Bioavailability of an extemporaneous suspension of propafenone made from tablets.
    Olguín HJ; Pérez CF; Pérez JF; Mendiola BR; Portugal MC; Chávez JB
    Biopharm Drug Dispos; 2006 Jul; 27(5):241-5. PubMed ID: 16586461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers.
    Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Lujàn Rangel R; de Lago A; Trejo D; Gonzàlez-de la Parra M; Namur S
    Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bioavailability of digoxin tablets in cardiac insufficiency patients].
    Kholodov LE; Grigor'eva EA; Glezer MG; Sabel'nikova EA
    Kardiologiia; 1980 Oct; 20(10):68-73. PubMed ID: 7441963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
    Khan MK; Khan MF; Khan H; Mustafa G
    Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparative study of the absolute bioavailability of four oral digoxin preparations (author's transl)].
    Rietbrock N; Alken RG; Ebert W
    Arzneimittelforschung; 1979; 29(11):1742-5. PubMed ID: 583489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Time-controlled release pseudoephedrine tablets: bioavailability and in vitro/in vivo correlations.
    Halsas M; Penttinen T; Veski P; Jürjenson H; Marvola M
    Pharmazie; 2001 Sep; 56(9):718-23. PubMed ID: 11593992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biological availability of digoxin from Lanoxin produced in the United Kingdom.
    Johnson BF; Fowle AS; Lader S; Fox J; Munro-Faure AD
    Br Med J; 1973 Nov; 4(5888):323-6. PubMed ID: 4758424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of an extended-release theophylline product in cats.
    Guenther-Yenke CL; McKiernan BC; Papich MG; Powell E
    J Am Vet Med Assoc; 2007 Sep; 231(6):900-6. PubMed ID: 17867974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative biopharmaceutical study of tegalide].
    Lopatina NB; Lebedeva MN
    Med Parazitol (Mosk); 2000; (1):27-9. PubMed ID: 10808715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of food on the rate and extent of absorption of theophylline after single dose oral administration of a controlled release tablet.
    Lagas M; Jonkman JH
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):424-6. PubMed ID: 4044074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
    Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
    Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
    Gordon MS; Chowhan Z
    Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bioavailability of digoxin from tablets. I. In vitro characterization of digoxin tablets.
    Nyberg L; Bratt L; Forsgren A; Hugosson S
    Acta Pharm Suec; 1974 Nov; 11(5):447-58. PubMed ID: 4440503
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparative bioavailability of two tablet formulations of metoclopramide hydrochloride.
    el-Sayed YM; Niazy EM; al-Rayes S; Ismail AO; Gouda MW
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):136-9. PubMed ID: 7599911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioavailability of digoxin in man after oral administration of preparations with different dissolution rate.
    Nyberg L
    Acta Pharmacol Toxicol (Copenh); 1977; 40 Suppl 3():1-48. PubMed ID: 301340
    [No Abstract]   [Full Text] [Related]  

  • 58. Maximal bioavailability of digoxin from tablets and oral solution in steady state.
    Manninen V; Reissell P; Ojala K
    Acta Med Scand; 1976; 199(6):487-9. PubMed ID: 937075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An improvement in digoxin bioavailability. Studies with soft gelatin capsules containing a solution of digoxin.
    Alvisi V; Longhini C; Bagni B; Portaluppi F; Ruina M; Fersini C
    Arzneimittelforschung; 1979; 29(7):1047-50. PubMed ID: 582997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.
    Johnson BF; Smith G; French J
    Br J Clin Pharmacol; 1977 Apr; 4(2):209-11. PubMed ID: 861135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.